Avantor, Inc. ($AVTR) Stock Forecast: Up 5.3% Today

What is Avantor, Inc.?

AVTR (Avantor) is a leading provider of mission-critical products and services to customers in the biopharma, healthcare, education, and government industries. The overall market sentiment has been positive today with a strong bullish movement.

Why is Avantor, Inc. going up?

AVTR stock is up 5.3% on Aug 22, 2025 16:07

• An investment firm has taken a stake in Avantor, believing that the company's underperformance is due to internal issues within the leadership team.
• This development has likely sparked investor optimism as the involvement of an activist investor suggests potential strategic changes and improvements within the company.
• The market movement could be a reflection of investor confidence in the investment firm's ability to unlock value in Avantor through strategic initiatives and operational enhancements.

AVTR Price Chart

AVTR Technical Analysis

AVTR News

Engine Capital takes a stake in Avantor. Activist sees several ways to create value

Engine believes that Avantor's significant underperformance is a consequence of self-inflicted mistakes rooted in a flawed leadership team and framework.

https://www.cnbc.com/2025/08/16/engine-capital-takes-a-stake-in-avantor-activist-sees-several-ways-to-create-value.html

Trending Today

Hedera Hashgraph ($HBAR) Crypto Forecast: Up 5.3% Today

Binance Coin ($BNB) Crypto Forecast: Up 5.1% Today

Stellar ($XLM) Crypto Forecast: Up 5.0% Today

Solana ($SOL) Crypto Forecast: Up 5.1% Today

Cardano ($ADA) Crypto Forecast: Up 5.0% Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.0% Today

Pendle ($PENDLE) Crypto Forecast: Up 5.3% Today

Polkadot ($DOT) Crypto Forecast: Up 5.1% Today

Sei ($SEI) Crypto Forecast: Up 5.3% Today

Cytokinetics, Incorporated ($CYTK) Stock Forecast: Down 6.3% Today

Avantor, Inc. Price History

25.03.2025 - AVTR Stock was down 16.0%

• AVTR's Q1 earnings meeting estimates may have been perceived as lackluster by investors, leading to a bearish movement in the stock.
• The slight revenue surprise of 1.72% might not have been enough to offset any concerns about the company's future growth prospects.
• Investors may be looking for stronger signals of growth and performance from AVTR to regain confidence in the stock, contributing to the bearish market movement today.

25.03.2025 - AVTR Stock was down 20.4%

• Q1 sales for Avantor dropped by 6%, falling $30 million below expectations, which likely influenced the bearish trend.
• The resignation of CEO Stubblefield, a change in company strategy, and an increased cost savings target of $400 million may have introduced uncertainty and negative sentiment among investors.
• Despite meeting earnings predictions, a modest revenue surprise of 1.72% may not have been enough to alleviate concerns about the sales decrease and leadership adjustments, contributing to the market's bearish direction.
• General market volatility likely heightened the stock's decline, in line with observations on unpredictable market fluctuations leading to increased volatility trading.

25.09.2024 - AVTR Stock was down 5.5%

• The strong bearish movement in AVTR stock could be attributed to profit-taking by investors after the stock beat Q3 earnings estimates. This could indicate that some investors are selling off their positions to lock in profits.
• The divestiture deal with Audax to sell its clinical services business may have also contributed to the bearish movement, as investors may be uncertain about the impact of this strategic decision on the company's future growth prospects.
• Despite beating earnings estimates, the slight revenue surprise may have raised concerns among investors about the company's ability to sustain its growth momentum in the coming quarters, leading to a bearish sentiment in the market.
• Overall, the combination of profit-taking post-earnings beat and uncertainty surrounding the divestiture deal could have driven the bearish movement in AVTR stock today.

15.00.2025 - AVTR Stock was up 1.7%

• Avantor, Inc. is a leading global provider of products, services, and solutions for professionals in the life sciences and advanced technologies industries. The company aims to enable innovative research and healthcare solutions.
• CareDx (CDNA) saw a rise in its shares, but recent trends in earnings estimate revisions may not lead to further price increases in the short term. This shift in investor focus could be boosting the stock price of Avantor, Inc.
• A comparison between Pediatrix Medical Group (MD) and Avantor, Inc. is being made to gauge which stock is more appealing to value investors. This comparison may have underscored the growth potential and value proposition of Avantor, Inc., contributing to its current bullish movement.

28.03.2025 - AVTR Stock was down 5.3%

• The stock of Avantor witnessed a downward movement during the latest trading session.
• Analysts revised their projections for Avantor following the first-quarter results, hinting at potential apprehensions about its future performance.
• Factors such as the company's failure to meet sales expectations, the CEO's resignation, and a strategic shift in direction could have influenced the prevailing negative market sentiment.
• The overall market outlook for Avantor appears to be influenced by internal organizational changes and external market conditions, leading to a bearish trajectory in the stock's value.

28.03.2025 - AVTR Stock was down 6.0%

• AVTR stock experienced a bearish movement despite reporting in-line earnings for Q1, with revenues slightly down year-over-year. This could have contributed to the negative market sentiment.
• Analysts cutting their forecasts after the Q1 results may have added to the bearish pressure on AVTR stock, as it indicates a lack of confidence in the company's future performance.
• The news of Avantor's CEO stepping down and the company planning a leadership change and strategy shift might have created uncertainty among investors, leading to the bearish market movement.
• Overall, the combination of missed revenue estimates, analyst downgrades, and leadership changes likely fueled the bearish sentiment surrounding AVTR stock.

22.07.2025 - AVTR Stock was up 5.3%

• An investment firm has taken a stake in Avantor, believing that the company's underperformance is due to internal issues within the leadership team.
• This development has likely sparked investor optimism as the involvement of an activist investor suggests potential strategic changes and improvements within the company.
• The market movement could be a reflection of investor confidence in the investment firm's ability to unlock value in Avantor through strategic initiatives and operational enhancements.

06.04.2025 - AVTR Stock was down 5.2%

• Concerns about margin and growth prompted a downgrade of Avantor by Goldman Sachs, resulting in a substantial decline in the stock price.
• Avantor's Q1 sales falling below estimates and a decrease in organic sales were contributing factors to the prevalent negative sentiment towards the stock.
• The downgrade by Goldman Sachs along with the underwhelming sales figures likely added to investor uncertainty, leading to the stock's bearish movement today.

07.01.2025 - AVTR Stock was down 5.7%

• Despite surpassing adjusted EPS estimates, Q4 net sales for Avantor declined by 2% YoY, falling short of expectations, potentially contributing to the bearish market response.
• The forecast of 1%-3% organic revenue growth for 2025 may have underwhelmed investors seeking more robust growth forecasts.
• The combination of the mixed Q4 earnings report and the absence of a clear beat in earnings expectations likely created investor uncertainty, driving the bearish market trend for Avantor today.

10.05.2025 - AVTR Stock was up 5.2%

• Avantor's bullish movement today could be attributed to positive market sentiment towards the life sciences and advanced technology sectors.
• Investors might be optimistic about Avantor's growth potential and strong performance in the industry.
• The lack of significant negative news or developments related to the company could have also contributed to the bullish movement.

01.07.2025 - AVTR Stock was down 20.5%

• AVTR's Q2 earnings fell short of estimates, with a -4.00% surprise in earnings and a +0.38% surprise in revenue.
• The disappointing earnings likely contributed to the bearish movement in AVTR's stock price today.
• Investors may have reacted negatively to the missed estimates, causing a sell-off in AVTR shares.
• The market may be cautious about AVTR's future performance based on the clues provided by the Q2 earnings results.

01.07.2025 - AVTR Stock was down 17.0%

• Avantor's Q2 earnings report fell short of expectations, with adjusted EPS missing estimates and revenue remaining nearly flat organically.
• The adjusted EBITDA margin decline to 16.6% and the decrease in net income from the previous year contributed to the bearish movement.
• Investor sentiment may have been negatively impacted by the company's bioprocessing shortfalls, customer headwinds, and continued margin pressure, leading to the stock's decline.
• The disappointing earnings results and lack of clarity on future performance may have prompted investors to sell off their positions, causing the bearish market movement for Avantor today.